Cargando…
Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study
BACKGROUND: The interleukin-1 pathway has been linked to pancreatic diseases. We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL-1RA) levels reduce the risk of acute and chronic pancreatitis and pancreatic cancer. METHODS: Genetic variants...
Autores principales: | Yuan, Shuai, Miao, Yuyang, Ruan, Xixian, Chen, Jie, Li, Xue, Larsson, Susanna C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538534/ https://www.ncbi.nlm.nih.gov/pubmed/37781392 http://dx.doi.org/10.3389/fimmu.2023.1240754 |
Ejemplares similares
-
Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses
por: Chen, Jie, et al.
Publicado: (2023) -
Depression and 24 gastrointestinal diseases: a Mendelian randomization study
por: Ruan, Xixian, et al.
Publicado: (2023) -
Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis
por: Yuan, Shuai, et al.
Publicado: (2023) -
Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations
por: Yuan, Shuai, et al.
Publicado: (2022) -
Bidirectional Association between Major Depressive Disorder and Gastroesophageal Reflux Disease: Mendelian Randomization Study
por: Miao, Yuyang, et al.
Publicado: (2022)